共 50 条
- [21] Increased Epstein-Barr virus reactivation but similar incidence of post-transplant lymphoproliferative disorders due to pre-emptive rituximab therapy following allogeneic hematopoietic stem cell transplantation in the letermovir era for cytomegalovirus prophylaxis BONE MARROW TRANSPLANTATION, 2025,
- [30] Use of Rituximab in Epstein-Barr Virus Infection Following Allogeneic Hematopoietic Stem Cell Transplantation JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (05): : 2439 - 2443